Kang Bo Lee

A nucleotide polymorphism in ERCC1 in human ovarian cancer cell lines and tumor tissues

Jing Yu, Mu Chuanjie, Kang Bo Lee et al. · Mutation Research/Mutation Research Genomics · 1997 · 111 citations

Nucleotide Polymorphism, Oncology, Medicine +9

Cisplatin sensitivity/resistance in UV repair-deficient Chinese hamster ovary cells of complementation groups 1 and 3

Kang Bo Lee, R. J. Parker, Vilhelm A. Bohr et al. · Carcinogenesis · 1993 · 100 citations

A Phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis

David L. Bartlett, Joseph F. Buell, Steven K. Libutti et al. · Cancer · 1998 · 81 citations · Full text

Pharmacokinetics of Cisplatin Administered by Continuous Hyperthermic Peritoneal Perfusion (CHPP) to Patients with Peritoneal Carcinomatosis

Hea‐Kyoung Cho, Richard M. Lush, David L. Bartlett et al. · The Journal of Clinical Pharmacology · 1999 · 46 citations

Surgical Oncology, Pharmacotherapy, Metronomic Chemotherapy +16

Synergistic effect and possible mechanisms of tumor necrosis factor and cisplatin cytotoxicity under moderate hyperthermia against gastric cancer cells

Joseph F. Buell, Eddie Reed, Kang Bo Lee et al. · Annals of Surgical Oncology · 1997 · 26 citations

Inflammation, Tumor Necrosis Factor, Gastric Cancer Cells +14